{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:55:31Z","timestamp":1791395731847,"version":"4.3.3"},"reference-count":16,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2026,9,19]]},"DOI":"10.1136\/thorax-2026-225710","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:20:30Z","timestamp":1791393630000},"page":"thorax-2026-225710","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Breath of fresh air for soluble guanylate cyclase (sGC) therapy: results from the ATMOS study"],"prefix":"10.1136","clinical-trial-number":[{"clinical-trial-number":"nct06635850","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct07333183","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Michael J","family":"Plunkett","sequence":"first","affiliation":[{"name":"Pulmonary Hypertension Department, Royal Brompton Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4287-1173","authenticated-orcid":false,"given":"Stephen John","family":"Wort","sequence":"additional","affiliation":[{"name":"Pulmonary Hypertension Department, Royal Brompton Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"2026100710201938000_thorax-2026-225710v1.1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00879-2022"},{"key":"2026100710201938000_thorax-2026-225710v1.2","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0183-2023","article-title":"The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase","volume":"33","author":"Benza","year":"2024","journal-title":"Eur Respir Rev"},{"key":"2026100710201938000_thorax-2026-225710v1.3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S2213-2600(20)30532-4","article-title":"Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial","volume":"9","author":"Hoeper","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2026100710201938000_thorax-2026-225710v1.4","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1111\/bph.15698","article-title":"Soluble GC stimulators and activators: Past, present and future","volume":"181","author":"Sandner","year":"2024","journal-title":"Br J Pharmacol"},{"key":"2026100710201938000_thorax-2026-225710v1.5","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-022-02189-1","article-title":"Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC","volume":"23","author":"Becker-Pelster","year":"2022","journal-title":"Respir Res"},{"key":"2026100710201938000_thorax-2026-225710v1.6","doi-asserted-by":"crossref","unstructured":"Ghofrani H-A , Leuchte HH , Al-Hiti H , et al . Phase 1b ATMOS trial of the inhaled sGC activator mosliciguat in patients with PAH\/CTEPH. Thorax 2025. doi:10.1136\/thorax-2025-224583","DOI":"10.1136\/thorax-2025-224583"},{"key":"2026100710201938000_thorax-2026-225710v1.7","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00105914"},{"key":"2026100710201938000_thorax-2026-225710v1.8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01110-2024"},{"key":"2026100710201938000_thorax-2026-225710v1.9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200301-147OC"},{"key":"2026100710201938000_thorax-2026-225710v1.10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98320-1","article-title":"Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmonary hypertension","volume":"11","author":"Tura-Ceide","year":"2021","journal-title":"Sci Rep"},{"key":"2026100710201938000_thorax-2026-225710v1.11","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.03.00063203"},{"key":"2026100710201938000_thorax-2026-225710v1.12","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13630"},{"key":"2026100710201938000_thorax-2026-225710v1.13","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-014-0123-7","article-title":"Oxidative stress-dependent activation of collagen synthesis is induced in human pulmonary smooth muscle cells by sera from patients with scleroderma-associated pulmonary hypertension","volume":"9","author":"Boin","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"2026100710201938000_thorax-2026-225710v1.14","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0137-2025","article-title":"Management of pulmonary arterial hypertension in systemic sclerosis: from classical treatments to new horizons","volume":"35","author":"Villa","year":"2026","journal-title":"Eur Respir Rev"},{"key":"2026100710201938000_thorax-2026-225710v1.15","unstructured":"Roivant . Roivant announces positive results from phocus study of mosliciguat in patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD) and unveils ongoing phase 3 phrontier study. 2026. Available: https:\/\/investor.roivant.com\/news-releases\/news-release-details\/roivant-announces-positive-results-phocus-study-mosliciguat"},{"key":"2026100710201938000_thorax-2026-225710v1.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008470"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2026-225710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:20:31Z","timestamp":1791393631000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2026-225710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":16,"alternative-id":["10.1136\/thorax-2026-225710"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2026-225710","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]}}}